INO
Inovio Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
INO Filings
Filing Date
Form Description
Form Type
2026-01-30
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-30 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-27
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-27 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-27
Form 8-K - Current report
Key Events
2026-01-27 · Key Events
Form 8-K - Current report
2025-12-29
Form 8-K - Current report
Key Events
2025-12-29 · Key Events
Form 8-K - Current report
2025-12-08
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-08 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-05
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-05 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-13 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
